SlideShare a Scribd company logo
1 of 32
Download to read offline
PHARMACEUTICAL MARKET & TRENDS
WHY GLOBAL PHARMACEUTICAL MARKET IS GROWING ?
1. Aging
2. Growing population
3. Rising income levels,
4. Emerging medical conditions
5. Emergence of new diseases.
MARKET SHARE OF
GLOBAL PHARMA
MARKET
•45.33%
North America
•20.24%
Europe
•20.24%
Asia Pacific
•7.53%
Latin America
•2.96%
Middle East and
Africa
Pharmaceutical industry worth
USD 1.57 trillion
STAKEHOLDERS IN
PHARMACEUTICAL
• General public,
patients, health
providers, health
related institutions
and the government
Corporate
management
Regulatory
Institutions
Research and
Development
End User
The goal of the pharmaceutical
industry, at large, is to lead the
discovery, development,
production, and marketing
processes in relation to drugs
and other products that can be
used as and for medication
MARKET DRIVERS
Growing drug
development
costs
Monitoring
issues and lack
of
standardization
Loss of control
Data security
issues
Market Restraints
PHARMA VALUE
CHAIN
Products
Information/Control
Money
GLOBALHEALTHCARE
TRENDS
Nasir Saeed Khan - https://catchonpakistan.com/
Nasir Saeed Khan - https://catchonpakistan.com/
THE FUTURE
OF LIFE
SCIENCES
AND
HEALTHCARE
LOGISTICS
Nasir Saeed Khan - https://catchonpakistan.com/
Nasir Saeed Khan - https://catchonpakistan.com/
Nasir Saeed Khan - https://catchonpakistan.com/
Advancing Data
Analytics
• Big Data
Increasing Visibility
through
Connectivity
• Internet of Things
Healthcare On-
Demand
• On-Demand Delivery
Automating for
Speed and Accuracy
• Robotics and
Automation
Increasing Efficiency
• Augmented Reality
On-demand
manufacturing
• Additive Manufacturing
Nasir Saeed Khan - https://catchonpakistan.com/
Nasir Saeed Khan - https://catchonpakistan.com/
PAKISTAN PHARMACEUTICAL
MARKET
• 650+ registered operational companies
• National operational companies 620
• Multinational companies - 30
• Un-registered companies - 1500+ plus
• Companies are located in KHI, HDD, MUX, FSD, LHE, RWP/ISB and PEW
21%
40%
20%
19%
Sind
Punjab
KPK
Balochistan
Provincial Business
Share
% of Pharma
URBAN - RURAL
0 20 40 60 80 100
Sind
Punjab
KPK
Balochistan
Urban Rular
43% 57%
41.9% 58.1%
59.6% 40.4%
69.8% 30.2%
Retail Market
49%
W/S Market
32%
Institutions
19%
SECTOR WISE
BUSINESS
PAKISTAN PHARMA MARKET
National
companies
66%
Multinational
34%
Top 15
companies
46%
Pakistan is estimated by June 2021 - Rs. 615.48 billion, growing at the rate of 22.54% (2021 vs
2020), 15.62% (4 years CAGR)
Formulation
Basic manufacturing
Semi-basic manufacturing
Repacking
Drug Companies - Basis of License in Pakistan
Top Pharma Companies in Pakistan
Glaxo smith kline
Getz
Abbott
Sami
Searle
Hilton
Feroz sons
Pfizer
,
Bayer
Macter
PharmEvo
MartinDow
Novartis
Sanofi
Bosch
Barret Hodgson
PHARMACEUTICAL SUPPLY CHAIN
Material procurement and manufacturing Drug Marketing, distribution
And dispensing
Supply chain - Areas of potential disruption
Excipients and other
chemicals and
materials
API manufacturing
APIs and excipients
formulated into the finished
drug product are often
sourced from outside the US
Formulation
manufacturing
Packing and
Labeling
Marketing and
distribution
Retailers /
Pharmacy
Hospitals/state
departments
Consumers
▪ Disruption of any of the connected components in the
pharmaceutical supply chain can lead to potential drug delays.
▪ Manufacturer reliance on sporadic raw material supplies for drug
APIs, excipients and formulation, as well as packaging and
labeling, can cause production and supply bottlenecks.
Chemical building blocks, regulatory
starting materials and chemical
intermediates
Resin-based bottles and films, paper
cartons and labels, stainless steel
needles and other materials
Raw material sourcing from different parts of the world
Wholesalers
Nasir Saeed Khan - https://catchonpakistan.com/
Nasir Saeed Khan - https://catchonpakistan.com/
Manufacturing
Plant
• Stage 1
Central
Warehouse
• Stage 2
CFA
• Stage 3
Distributor(s)
• Stage 4
Retailers
• Stage 5
Pharma Distribution Practices - Pakistan
Nasir Saeed Khan - https://catchonpakistan.com/
Functions of Distributions Network
1. Warehousing
2. Physical distribution
3. Financing
4. Market Feedback
5. Promotional Activities
6. Follow up on Expiry Issues
Pharmaceutical marketing functions
1. Company’s Own Sales Team
2. Contractual Sales Team
3. Company’s own distribution
4. National Contractual Distribution
5. Regional Contractual Distribution
Types of Distribution Channels
Nasir Saeed Khan - https://catchonpakistan.com/
Supply Chain Performance Components-Pharmaceutical
Flexibility Performance
• Demand variations
• Poor manufacturing
• Supplier performance
• Poor delivery performance
• New products, new markets, or
new competitors
Resource Performance
• Total cost of resources used
• Total cost of distribution including
transportation and handling cost
• Total cost of manufacturing,
including labor, maintenance, and
re-work cost.
• Cost associated with held
inventory
• Return on investment
Output Performance
• Sales
• Order Fill Rate
• On-Time Deliveries
• Customer Response Time
• Shipping Errors
• Manufacturing Lead Time
• Customer Complaints
Nasir Saeed Khan - https://catchonpakistan.com/
7 Pillars Of Pharma Distributions - Pakistan
Nasir Saeed Khan - https://catchonpakistan.com/
Distribution practices-Pharmaceutical products
1. Organization and management
2. Personnel
3. Quality management
4. Premises, warehousing and storage
5. Vehicles and equipment
6. Shipment containers and container labelling
7. Dispatch
8. Transportation and products in transit
9. Documentation
10. Repackaging and relabeling
11. Complaints
12. Recalls
13. Rejected and returned products
14. Counterfeit pharmaceutical products
15. Importation
16. Contract activities
Nasir Saeed Khan - https://catchonpakistan.com/
Distribution setup – Deciding Factors
Company Profile
Marketing Focus
Area Coverage
Nature of Association
Services Needed from Distribution
ROI Sheet for Pharma
%age review of medicine
MRP
• Market Retail Price
TP
• Trade Price
• 15% less from MRP
• Profit of retailer
DP
• Distribution Price
• 10% less from TP (Profit of Dist.)
• (Purchasing price by the company.
%age review of Distributor’s expenses
3.97%
• Fuel Expenses for
supplies
2.87%
• Staff salaries and
office Expenses
3.16%
• Net profit
OPPORTUNITIES
Transportation
OPPORTUNITIES
WAREHOUSING
THANK YOU
Your Questions?
Nasir Saeed Khan - https://catchonpakistan.com/

More Related Content

Similar to Supply Chain in Pakistan - Growing opportunities of Pharmaceutical Sector.pdf

Final supply chain in pharma
Final supply chain in pharmaFinal supply chain in pharma
Final supply chain in pharma
Jai Verma
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
Wildfrontech
 
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
iosrjce
 

Similar to Supply Chain in Pakistan - Growing opportunities of Pharmaceutical Sector.pdf (20)

Regulatory affairs by Aneela Saleem
Regulatory affairs by Aneela SaleemRegulatory affairs by Aneela Saleem
Regulatory affairs by Aneela Saleem
 
Improving the Patient Experience Through Pharmacy
Improving the Patient Experience Through PharmacyImproving the Patient Experience Through Pharmacy
Improving the Patient Experience Through Pharmacy
 
Indian pharma industry
Indian pharma industryIndian pharma industry
Indian pharma industry
 
7th pharmacovigilance 2014
7th pharmacovigilance 20147th pharmacovigilance 2014
7th pharmacovigilance 2014
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
 
Member Pharmacy Contract Approach
Member Pharmacy Contract ApproachMember Pharmacy Contract Approach
Member Pharmacy Contract Approach
 
Acquired Orphan Blood Diseases Therapeutics Market PPT: Growth, Outlook, Dema...
Acquired Orphan Blood Diseases Therapeutics Market PPT: Growth, Outlook, Dema...Acquired Orphan Blood Diseases Therapeutics Market PPT: Growth, Outlook, Dema...
Acquired Orphan Blood Diseases Therapeutics Market PPT: Growth, Outlook, Dema...
 
Who prequalification program
Who prequalification programWho prequalification program
Who prequalification program
 
Final supply chain in pharma
Final supply chain in pharmaFinal supply chain in pharma
Final supply chain in pharma
 
Oncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End UserOncology Drugs: The journey From Manufacturer To The End User
Oncology Drugs: The journey From Manufacturer To The End User
 
Enterprise Labeling for the Pharmaceutical Industry
Enterprise Labeling for the Pharmaceutical IndustryEnterprise Labeling for the Pharmaceutical Industry
Enterprise Labeling for the Pharmaceutical Industry
 
Acquired Orphan Blood Diseases Therapeutics Market PPT: Growth, Outlook, Dema...
Acquired Orphan Blood Diseases Therapeutics Market PPT: Growth, Outlook, Dema...Acquired Orphan Blood Diseases Therapeutics Market PPT: Growth, Outlook, Dema...
Acquired Orphan Blood Diseases Therapeutics Market PPT: Growth, Outlook, Dema...
 
Us registration for foreign drugs
Us registration for foreign drugsUs registration for foreign drugs
Us registration for foreign drugs
 
The Global Pharmaceutical Industry and key drivers
The Global Pharmaceutical Industry and key driversThe Global Pharmaceutical Industry and key drivers
The Global Pharmaceutical Industry and key drivers
 
Clinical trial supply management
Clinical trial supply managementClinical trial supply management
Clinical trial supply management
 
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
Hans van Bruggen | Semantic interoperability to manage medicinal data and exc...
 
9th pharmacovigilance 2015
9th pharmacovigilance 20159th pharmacovigilance 2015
9th pharmacovigilance 2015
 
Pharmaceutical preformulation and formulation
Pharmaceutical preformulation  and formulationPharmaceutical preformulation  and formulation
Pharmaceutical preformulation and formulation
 
PRODUCT AWARENESS LS.pptx
PRODUCT AWARENESS  LS.pptxPRODUCT AWARENESS  LS.pptx
PRODUCT AWARENESS LS.pptx
 
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
 

More from Nasir Tareen (7)

Strategy retail store in pakistan -Bakery focused
Strategy   retail store in pakistan -Bakery focusedStrategy   retail store in pakistan -Bakery focused
Strategy retail store in pakistan -Bakery focused
 
Retail in Pakistan
Retail in PakistanRetail in Pakistan
Retail in Pakistan
 
The simple scalping strategy rules
The simple scalping strategy rules  The simple scalping strategy rules
The simple scalping strategy rules
 
Short selling basics more profitable
Short selling basics   more profitable Short selling basics   more profitable
Short selling basics more profitable
 
Opening range breakout trading strategy
Opening range breakout trading strategyOpening range breakout trading strategy
Opening range breakout trading strategy
 
University for industry Pakistani context
University for industry   Pakistani contextUniversity for industry   Pakistani context
University for industry Pakistani context
 
Value Chain Partnership in Pakistan
Value Chain Partnership in PakistanValue Chain Partnership in Pakistan
Value Chain Partnership in Pakistan
 

Recently uploaded

Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
DanielOliver74
 
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptxUrinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
AnushriSrivastav
 

Recently uploaded (20)

TERMINOLOGY PPT few defination of clinical research terminologys
TERMINOLOGY PPT few defination of clinical research terminologysTERMINOLOGY PPT few defination of clinical research terminologys
TERMINOLOGY PPT few defination of clinical research terminologys
 
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
Jesse Jhaj: Building Relationships with Patients as a Doctor or Healthcare Wo...
 
Mike Lowe’s cancer fight lowe strong shirt
Mike Lowe’s cancer fight lowe strong shirtMike Lowe’s cancer fight lowe strong shirt
Mike Lowe’s cancer fight lowe strong shirt
 
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
Production.pptx\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\
 
Importance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docxImportance of Diet on Dental Health.docx
Importance of Diet on Dental Health.docx
 
GOUT and it's Management with All the catagories like; Defination, Type, Sym...
GOUT and it's Management with All the catagories like;  Defination, Type, Sym...GOUT and it's Management with All the catagories like;  Defination, Type, Sym...
GOUT and it's Management with All the catagories like; Defination, Type, Sym...
 
Colonoscopy Screening And Age: Adapting Guidelines For Different Life Stages
Colonoscopy Screening And Age: Adapting Guidelines For Different Life StagesColonoscopy Screening And Age: Adapting Guidelines For Different Life Stages
Colonoscopy Screening And Age: Adapting Guidelines For Different Life Stages
 
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF BED PAN BY ANUSHRI SRIVASTAVA.pptx
 
The Best Foot and Ankle Center of Arizona
The Best Foot and Ankle Center of ArizonaThe Best Foot and Ankle Center of Arizona
The Best Foot and Ankle Center of Arizona
 
Renal Replacement Therapy - ICU Guidlines
Renal Replacement  Therapy - ICU GuidlinesRenal Replacement  Therapy - ICU Guidlines
Renal Replacement Therapy - ICU Guidlines
 
Leaukemia and it cause sign and symptoms
Leaukemia and it cause sign and symptomsLeaukemia and it cause sign and symptoms
Leaukemia and it cause sign and symptoms
 
The Docs PPG - 30.01.2024.pptx..........
The Docs PPG - 30.01.2024.pptx..........The Docs PPG - 30.01.2024.pptx..........
The Docs PPG - 30.01.2024.pptx..........
 
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, IndiaDr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
Dr. Gaurav Gangwani: Leading Interventional Radiologist in Mumbai, India
 
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptxPhRMA Vaccines Deck_05-15_2024_FINAL.pptx
PhRMA Vaccines Deck_05-15_2024_FINAL.pptx
 
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
2024 03 Monumental Mistakes in EMS BAD EMS v0.2.pdf
 
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptxASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
ASSISTING WITH THE USE OF URINAL BY ANUSHRI SRIVASTAVA.pptx
 
Occupational Therapy Management for Parkinson's Disease - Webinar 2024
Occupational Therapy Management for Parkinson's Disease - Webinar 2024Occupational Therapy Management for Parkinson's Disease - Webinar 2024
Occupational Therapy Management for Parkinson's Disease - Webinar 2024
 
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptxUrinary Elimination BY ANUSHRI SRIVASTAVA.pptx
Urinary Elimination BY ANUSHRI SRIVASTAVA.pptx
 
Dr Sujit Chatterjee At Hiranandani Hospital.pdf
Dr Sujit Chatterjee At Hiranandani Hospital.pdfDr Sujit Chatterjee At Hiranandani Hospital.pdf
Dr Sujit Chatterjee At Hiranandani Hospital.pdf
 
Best Way 30-Days Keto Meal Plan For Diet
Best Way 30-Days Keto Meal Plan For DietBest Way 30-Days Keto Meal Plan For Diet
Best Way 30-Days Keto Meal Plan For Diet
 

Supply Chain in Pakistan - Growing opportunities of Pharmaceutical Sector.pdf

  • 2. WHY GLOBAL PHARMACEUTICAL MARKET IS GROWING ? 1. Aging 2. Growing population 3. Rising income levels, 4. Emerging medical conditions 5. Emergence of new diseases.
  • 3. MARKET SHARE OF GLOBAL PHARMA MARKET •45.33% North America •20.24% Europe •20.24% Asia Pacific •7.53% Latin America •2.96% Middle East and Africa Pharmaceutical industry worth USD 1.57 trillion
  • 4. STAKEHOLDERS IN PHARMACEUTICAL • General public, patients, health providers, health related institutions and the government Corporate management Regulatory Institutions Research and Development End User The goal of the pharmaceutical industry, at large, is to lead the discovery, development, production, and marketing processes in relation to drugs and other products that can be used as and for medication
  • 5. MARKET DRIVERS Growing drug development costs Monitoring issues and lack of standardization Loss of control Data security issues Market Restraints
  • 7. GLOBALHEALTHCARE TRENDS Nasir Saeed Khan - https://catchonpakistan.com/ Nasir Saeed Khan - https://catchonpakistan.com/
  • 8. THE FUTURE OF LIFE SCIENCES AND HEALTHCARE LOGISTICS Nasir Saeed Khan - https://catchonpakistan.com/
  • 9. Nasir Saeed Khan - https://catchonpakistan.com/
  • 10. Nasir Saeed Khan - https://catchonpakistan.com/
  • 11. Advancing Data Analytics • Big Data Increasing Visibility through Connectivity • Internet of Things Healthcare On- Demand • On-Demand Delivery Automating for Speed and Accuracy • Robotics and Automation Increasing Efficiency • Augmented Reality On-demand manufacturing • Additive Manufacturing Nasir Saeed Khan - https://catchonpakistan.com/
  • 12. Nasir Saeed Khan - https://catchonpakistan.com/
  • 13. PAKISTAN PHARMACEUTICAL MARKET • 650+ registered operational companies • National operational companies 620 • Multinational companies - 30 • Un-registered companies - 1500+ plus • Companies are located in KHI, HDD, MUX, FSD, LHE, RWP/ISB and PEW
  • 15. URBAN - RURAL 0 20 40 60 80 100 Sind Punjab KPK Balochistan Urban Rular 43% 57% 41.9% 58.1% 59.6% 40.4% 69.8% 30.2%
  • 17. PAKISTAN PHARMA MARKET National companies 66% Multinational 34% Top 15 companies 46% Pakistan is estimated by June 2021 - Rs. 615.48 billion, growing at the rate of 22.54% (2021 vs 2020), 15.62% (4 years CAGR)
  • 19. Top Pharma Companies in Pakistan Glaxo smith kline Getz Abbott Sami Searle Hilton Feroz sons Pfizer , Bayer Macter PharmEvo MartinDow Novartis Sanofi Bosch Barret Hodgson
  • 21. Material procurement and manufacturing Drug Marketing, distribution And dispensing Supply chain - Areas of potential disruption Excipients and other chemicals and materials API manufacturing APIs and excipients formulated into the finished drug product are often sourced from outside the US Formulation manufacturing Packing and Labeling Marketing and distribution Retailers / Pharmacy Hospitals/state departments Consumers ▪ Disruption of any of the connected components in the pharmaceutical supply chain can lead to potential drug delays. ▪ Manufacturer reliance on sporadic raw material supplies for drug APIs, excipients and formulation, as well as packaging and labeling, can cause production and supply bottlenecks. Chemical building blocks, regulatory starting materials and chemical intermediates Resin-based bottles and films, paper cartons and labels, stainless steel needles and other materials Raw material sourcing from different parts of the world Wholesalers Nasir Saeed Khan - https://catchonpakistan.com/
  • 22.
  • 23. Nasir Saeed Khan - https://catchonpakistan.com/ Manufacturing Plant • Stage 1 Central Warehouse • Stage 2 CFA • Stage 3 Distributor(s) • Stage 4 Retailers • Stage 5 Pharma Distribution Practices - Pakistan
  • 24. Nasir Saeed Khan - https://catchonpakistan.com/ Functions of Distributions Network 1. Warehousing 2. Physical distribution 3. Financing 4. Market Feedback 5. Promotional Activities 6. Follow up on Expiry Issues Pharmaceutical marketing functions 1. Company’s Own Sales Team 2. Contractual Sales Team 3. Company’s own distribution 4. National Contractual Distribution 5. Regional Contractual Distribution Types of Distribution Channels
  • 25. Nasir Saeed Khan - https://catchonpakistan.com/ Supply Chain Performance Components-Pharmaceutical Flexibility Performance • Demand variations • Poor manufacturing • Supplier performance • Poor delivery performance • New products, new markets, or new competitors Resource Performance • Total cost of resources used • Total cost of distribution including transportation and handling cost • Total cost of manufacturing, including labor, maintenance, and re-work cost. • Cost associated with held inventory • Return on investment Output Performance • Sales • Order Fill Rate • On-Time Deliveries • Customer Response Time • Shipping Errors • Manufacturing Lead Time • Customer Complaints
  • 26. Nasir Saeed Khan - https://catchonpakistan.com/ 7 Pillars Of Pharma Distributions - Pakistan
  • 27. Nasir Saeed Khan - https://catchonpakistan.com/ Distribution practices-Pharmaceutical products 1. Organization and management 2. Personnel 3. Quality management 4. Premises, warehousing and storage 5. Vehicles and equipment 6. Shipment containers and container labelling 7. Dispatch 8. Transportation and products in transit 9. Documentation 10. Repackaging and relabeling 11. Complaints 12. Recalls 13. Rejected and returned products 14. Counterfeit pharmaceutical products 15. Importation 16. Contract activities
  • 28. Nasir Saeed Khan - https://catchonpakistan.com/ Distribution setup – Deciding Factors Company Profile Marketing Focus Area Coverage Nature of Association Services Needed from Distribution
  • 29. ROI Sheet for Pharma %age review of medicine MRP • Market Retail Price TP • Trade Price • 15% less from MRP • Profit of retailer DP • Distribution Price • 10% less from TP (Profit of Dist.) • (Purchasing price by the company. %age review of Distributor’s expenses 3.97% • Fuel Expenses for supplies 2.87% • Staff salaries and office Expenses 3.16% • Net profit
  • 32. THANK YOU Your Questions? Nasir Saeed Khan - https://catchonpakistan.com/